News

Welcome News:


One Nucleus welcomes the Government's support of Cambridge to continue developing as a destination to attract global investment and talent in life sciences through plans to create aspirational housing and communities for those employed in the sector.


Housing to Match Aspiration:

Having recently attended the London Stem Cell Conference, Oliver Herd, a trainee patent attorney at IP law firm Appleyard Lees IP LLP, reflects on some of the current activity in the stem cell field and how products, methods and consumables can be protected in Europe.

BioIVT’s standardized collection protocols and diverse donor base help facilitate molecular biomarker validation and ensure their clinical utility.


BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that it will highlight the integral role it is playing in liquid biopsy research at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo. This conference will be held from July 23-27 at the Anaheim Convention Center in Anaheim, CA.

The Health Systems Task Force is a public-private strategic partnership, bought together by Sir Pascal Soriot, CEO of Astrazenca, which gathers other CEOs and leaders from key stakeholders such as: 



  • GSK

  • Merck KGaA

  • Novo Nordisk

  • Roche

  • Samsung Biologicals

  • Sanofi

  • Karolinska Instituet

  • National Health Service England

  • the Sustainable Healthcare Coalition 

  • UNICEF

  • The University of Pavia

  • World Health Organizaton (WHO)


 

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company

The results from Eli Lilly's Phase 3 trial of Donanemab showed that the drug significantly slowed cogntive and functional decline for early symptomatic Alzheimer's disease patients, decreasing their risk of disease progression. Their recent press release stated that "nearly half of participants at earlier stage of disease on donanemab had no clinical progression at 1 year".


This study demonstrates the importance of an early diagnosis and brings hope to people with Alzheimer's disease.

Are you a vegan or vegetarian woman, at least 18 years old, live within 40 miles of Norwich and in good health?


The Quadram institute are conducting a 17-week study to investigate the use of hydroponically-grown, biofertified salad greens, and use of a dietary app, on iron and B12 status in vegan or vegetarian women of child-bearing age.

PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research


BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced today that it has acquired PrecisionMed, LLC, a leading supplier of high-quality human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics.

Oxford, UK, 18 July 2023 – PrecisionLife, a leading computational biology company driving precision medicine in complex chronic diseases, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This analysis opens the door for new precision diagnostic and therapeutic approaches to address the massive unmet medical need affecting the lives of millions of patients.

Pages